Sponsor Dossier
Medison Pharma
Sponsor Dossier for Medison Pharma. ARTG portfolio, PBS-listed brands, PBAC activity, AusPAR record — compiled by arcimedes.
About
Medison Pharma is an Australian Private Company with ABN 19659723403, registered in New South Wales. The entity is active.
Portfolio
Medison Pharma has 6 brands on the ARTG, of which 6 are indexable and 6 carry a Product Information document. 6 brands are PBS-listed, 6 have a PBAC outcome on record, and 6 have an AusPAR on record. Notable brands include AMVUTTRA,, GIVLAARI, KIMMTRAK, LIBTAYO, ONPATTRO, OXLUMO.
Therapeutic focus
— Rare Disease: 4 brands — Oncology: 2 brands
PBS footprint
6 brands are PBS-listed, with the latest PBS schedule date 2026-10-01.
Regulatory activity
The latest PBAC outcome is 2026-09-01, across 6 brands with a PBAC outcome on record. The latest AusPAR is 2025-06-17, across 6 brands with an AusPAR on record.